These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11119955)

  • 41. Immunosuppressive protocols at transplantation centers in Turkey.
    Haberal M; Demirağ A; Bilgin N; Arslan G; Büyükpamukçu N
    Transplant Proc; 1995 Oct; 27(5):2776-7. PubMed ID: 7482911
    [No Abstract]   [Full Text] [Related]  

  • 42. A randomized study comparing three cyclosporine-based regimens in cadaveric renal transplantation: results at 7 years.
    Tarantino A; Segoloni GP; Cambi V; Rizzo G; Altieri P; Mastrangelo F; Castagneto M; Salvadori M; Valente U; Cossu M; Federico S; Pisani F; Montagnino G; Messina M; Arisi L; Carmellini M; Piredda GB; Ponticelli C
    Transplant Proc; 1998 Aug; 30(5):1729-31. PubMed ID: 9723258
    [No Abstract]   [Full Text] [Related]  

  • 43. Long-term outcome of living-unrelated donor kidney transplantation.
    Prabhakar KS; Vathsala A; Woo KT
    Transplant Proc; 2000 Nov; 32(7):1807-8. PubMed ID: 11119945
    [No Abstract]   [Full Text] [Related]  

  • 44. Recurrence of membranous lupus glomerulonephritis two months after a renal cadaver transplant.
    Lauzurica R; Bonet J; Vaquero M; Torguet P; Serra A; Borrás M; Caralps A
    Transplant Proc; 1992 Feb; 24(1):108-9. PubMed ID: 1539197
    [No Abstract]   [Full Text] [Related]  

  • 45. Kidney transplantation at extremes of age: CsA eliminates the increased risk in recipients < or = 5 or > or = 55 years.
    MacDonell RC; Van Buren DH; Richie RE; Johnson HK; Nylander WA; Helderman JH; Ynares CM; Trusler LA; Green WF; Crowe DA
    Transplant Proc; 1994 Oct; 26(5):2518-21. PubMed ID: 7940774
    [No Abstract]   [Full Text] [Related]  

  • 46. Long-term outcome of tacrolimus rescue therapy in late rejection after renal transplantation.
    Budde K; Smettan S; Fritsche L; Waiser J; Giessing M; Kunz R; Türk I; Bauer S; Mai I; Neumayer HH
    Transplant Proc; 1998 Aug; 30(5):1780-1. PubMed ID: 9723280
    [No Abstract]   [Full Text] [Related]  

  • 47. Outcome of kidney transplantation in patients with systemic autoimmune diseases.
    Kliem V; Haubitz M; Ehlerding G; Nashan B; Schlitt HJ; Oldhafer KJ; Pichlmayr R; Koch KM; Brunkhorst R
    Transplant Proc; 1997; 29(1-2):957-8. PubMed ID: 9123606
    [No Abstract]   [Full Text] [Related]  

  • 48. The effect of delayed graft function and early graft rejection on renal transplant outcome.
    Marcén R; Pascual J; Orofino L; de la Cal MA; Teruel JL; Villafruela JJ; Rivera ME; Burgos FJ; Mampaso F; Ortuño J
    Transplant Proc; 1998 Aug; 30(5):1776-7. PubMed ID: 9723278
    [No Abstract]   [Full Text] [Related]  

  • 49. Renal transplantation for lupus nephritis: non-adherence and graft survival.
    Ntatsaki E; Vassiliou VS; Velo-Garcia A; Salama AD; Isenberg DA
    Lupus; 2019 Apr; 28(5):651-657. PubMed ID: 30982400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach.
    Turner CD; Bruce DS; Cronin DC; Loss GE; Grewal H; Siegel C; Millis JM; Newell KA; Davis B; Todo T; Thistlethwaite JR; Woodle ES
    Transplant Proc; 1998 Jun; 30(4):1234-5. PubMed ID: 9636501
    [No Abstract]   [Full Text] [Related]  

  • 51. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
    Pham PT; Pham PC
    Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
    Kehinde EO; Wheatley T; Feehally J; Nicholson ML; Veitch PS; Bell PR
    Transplant Proc; 1996 Jun; 28(3):1338-9. PubMed ID: 8658684
    [No Abstract]   [Full Text] [Related]  

  • 53. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
    Stone JH; Millward CL; Olson JL; Amend WJ; Criswell LA
    Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation.
    Wüthrich RP; Weinreich T; Schwarzkopf AK; Candinas D; Binswanger U
    Transplant Proc; 1998 Dec; 30(8):4096-7. PubMed ID: 9865310
    [No Abstract]   [Full Text] [Related]  

  • 55. Withdrawal of steroids from a cyclosporine-based regimen: pro.
    Ponticelli C
    Transplant Proc; 1998 Aug; 30(5):1782-4. PubMed ID: 9723281
    [No Abstract]   [Full Text] [Related]  

  • 56. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group
    Transplantation; 2001 Apr; 71(8):1091-7. PubMed ID: 11374408
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized trial to evaluate the use of increasing the steroid dose during conversion from cyclosporine to azathioprine.
    Roodnat JI; Zietse R; Rischen-Vos J; van Gelder T; IJzermans JN; Weimar W
    Transplant Proc; 1998 Jun; 30(4):1199-200. PubMed ID: 9636486
    [No Abstract]   [Full Text] [Related]  

  • 58. Long-term outcome of kidney transplantation after steroid withdrawal.
    Dunn T; Asolati M; Holman D; Raofi V; Lutrin F; Massad M; Pollak R; Benedetti E
    Transplant Proc; 1998 Aug; 30(5):1788-9. PubMed ID: 9723283
    [No Abstract]   [Full Text] [Related]  

  • 59. Long-term comparison of tacrolimus and cyclosporine-based immunosuppression in kidney recipients with grafts from non-heart-beating cadaver donor.
    Kinukawa T; Ohshima S; Ono Y; Fujita T; Hattori R; Tanaka K
    Transplant Proc; 1998 Jun; 30(4):1227-9. PubMed ID: 9636498
    [No Abstract]   [Full Text] [Related]  

  • 60. Renal recipients of haploidentical living donors treated with Neoral or conventional cyclosporine: a comparative follow-up of 3 years.
    Gracida C; Melchor JL
    Transplant Proc; 1998 Aug; 30(5):1742-3. PubMed ID: 9723262
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.